Full-Time

Territory Business Manager

Neuromuscular Sales

Posted on 3/13/2025

Takeda

Takeda

10,001+ employees

Develops and commercializes biopharmaceuticals and vaccines

Compensation Overview

$138.4k - $190.3kAnnually

+ Short-term Incentives + Long-term Incentives

Senior

Houston, TX, USA

Must live within the territory geography.

Category
Field Sales
Sales & Account Management
Required Skills
Marketing
Data Analysis
Requirements
  • Bachelor's degree required.
  • Must live within the territory geography.
  • 5+ years of demonstrated successful relevant healthcare sales experience including roles of increasing responsibility is required.
  • Able to travel 70% of the time, including ability to travel overnight and occasionally on weekends. Travel is required on occasion for internal meetings and conferences.
  • Must have authorization and ability to drive a company leased vehicle or rental.
Responsibilities
  • Achieve sales quotas and goals through growing product volume.
  • Conduct customer engagements to deliver sales presentations, provide technical and administrative product information, and educate on neuromuscular conditions and various Takeda support resources.
  • Understand influence points within the office and how each individual affects diagnosis, treatment, and the Rx/referral/order.
  • Participate in community education events and Neurology conferences for healthcare professionals and patients.
  • Analyze and interpret data for sales strategies and build and document a pipeline of opportunities along with territory and account plans.
  • Collaborate with multiple teams (Marketing, Patient Services, Alternate Site Team, Integrated Health Systems, Market Access, and National Accounts) to ensure high levels of customer satisfaction and pull through of opportunities within each geography.
  • Maintain compliance to our promotional and expense policies.
  • Embrace the patient-centric culture aligned to our values of Takeda-ism and follow PTRB (patient, trust, reputation, business) as a guide in decision making.
Desired Qualifications
  • Clinical sales background with experience in rare disease, Neurology/Neuromuscular Specialist, managing large/multi-state geography, and being accountable for own business strongly preferred.
  • It is preferred that you have experience in specialty sales (injectables/infusions) including specialty pharmacy/distribution, buy-&-bill/access, patient HUB.
  • Experience/understand how to work multiple sites of care and product channels (physician office, infusion centers, hospitals, specialty pharmacy) along with associated stakeholders.
  • Demonstrated success and experience in launch execution of new therapeutic options.

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and commercialize them, with a goal of launching up to 15 new products by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to provide life-changing therapies while ensuring that patient needs are prioritized and environmental risks are managed.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's collaboration with BridGene could enhance its immunology and neurology offerings.
  • The SEA AtM Summit highlights Takeda's commitment to expanding access to medicines in Asia.
  • Positive Phase III trial results for a cancer drug strengthen Takeda's oncology portfolio.

What critics are saying

  • Antitrust litigation in the US could impact Takeda's market position and reputation.
  • The $770 million deal with BridGene poses financial risks if outcomes aren't met.
  • Geopolitical risks could disrupt Takeda's global operations and supply chain.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and innovations.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.

Nyasa Times
Feb 6th, 2025
Forgotten Children: Mzimba's Tukuyu CBCC Struggles to Provide Basic Education

VillageReach, in partnership with Takeda Pharmaceutical Company Limited, has launched a new initiative aimed at strengthening health systems and improving...